Structural insights into the interaction of botulinum neurotoxin a with its neuronal receptor SV2C

被引:2
|
作者
Li, Xiaodan [1 ]
Brunner, Cyrill [2 ]
Wu, Yufan [1 ]
Leka, Oneda [1 ]
Schneider, Gisbert [2 ]
Kammerer, Richard A. [1 ]
机构
[1] Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland
[2] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, RETHINK, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
Botulinum neurotoxin; Synaptic vesicle glycoprotein 2; Protein receptor; Crystal structure; Surface plasmon resonance; Mutagenesis; Biophysics; Plasticity; Protein-protein interactions; Protein-carbohydrate interactions; CRYSTAL-STRUCTURE; PROTEIN-RECEPTOR; BACILLUS-THURINGIENSIS; SYNAPTOTAGMIN-I; TOXIN; BINDING; IDENTIFICATION; BLOCKADE; DOMAIN;
D O I
10.1016/j.toxicon.2019.11.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A dual-receptor interaction with a polysialoganglioside and synaptic vesicle glycoprotein 2 (SV2) is required for botulinum neurotoxin A (BoNT) toxicity. Here, we review what is currently known about the BoNT/A-SV2 interaction based on structural studies. Currently, five crystal structures of the receptor-binding domain (Hc) of BoNT subtypes A1 and A2 complexed to the large luminal domain (LD4) of SV2C have been determined. On the basis of the available structures, we will discuss the importance of protein-protein and protein-carbohydrate interactions for BoNT/A toxicity as well as the high plasticity of BoNT/A for receptor recognition by tolerating a variety of side-chain interactions at the interface. A plausible explanation how receptor-binding specificity of BoNT/A may be achieved without an extensive and conserved side chain-side chain interaction network will be provided.
引用
收藏
页码:36 / 43
页数:8
相关论文
共 50 条
  • [1] Capture assay for Botulinum Neurotoxin Type A utilizing the receptor protein SV2c
    Christian, Todd
    Shine, Nancy
    TOXICON, 2008, 51 : 2 - 2
  • [2] Structural basis of botulinum neurotoxin serotype A1 binding to human SV2A or SV2C receptors
    Azzaz, Fodil
    Hilaire, Didier
    Fantini, Jacques
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 373
  • [3] New SV2c construct for use in binding and detecting botulinum neurotoxin type A
    Christian, T.
    Suryadi, K.
    Shine, N.
    TOXICON, 2013, 68 : 84 - 84
  • [4] Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding
    Gustafsson, Robert
    Zhang, Sicai
    Masuyer, Geoffrey
    Dong, Min
    Stenmark, Pal
    TOXINS, 2018, 10 (04):
  • [5] SV2 is the protein receptor for botulinum neurotoxin A
    Dong, M
    Yeh, F
    Tepp, WH
    Dean, C
    Johnson, EA
    Janz, R
    Chapman, ER
    SCIENCE, 2006, 312 (5773) : 592 - 596
  • [6] Crystal structure of the BoNT/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C
    Roger M. Benoit
    Martin A. Schärer
    Mara M. Wieser
    Xiaodan Li
    Daniel Frey
    Richard A. Kammerer
    Scientific Reports, 7
  • [7] Crystal structure of the BoNT/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C
    Benoit, Roger M.
    Schaerer, Martin A.
    Wieser, Mara M.
    Li, Xiaodan
    Frey, Daniel
    Kammerer, Richard A.
    SCIENTIFIC REPORTS, 2017, 7
  • [8] CRYSTAL STRUCTURE OF THE BONT/A2 RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF ITS NEURONAL RECEPTOR SV2C
    Kammerer, Richard A.
    TOXICON, 2018, 156 : S55 - S56
  • [9] Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin
    Weisemann, Jasmin
    Stern, Daniel
    Mahrhold, Stefan
    Dorner, Brigitte G.
    Rummel, Andreas
    TOXINS, 2016, 8 (05):
  • [10] Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A
    Yamagata, Atsushi
    Ito, Kaori
    Suzuki, Takehiro
    Dohmae, Naoshi
    Terada, Tohru
    Shirouzu, Mikako
    NATURE COMMUNICATIONS, 2024, 15 (01)